BlackRock Institutional Trust’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14K Hold
51
﹤0.01% 3783
2016
Q3
$19K Hold
51
﹤0.01% 3816
2016
Q2
$18K Hold
51
﹤0.01% 3828
2016
Q1
$28K Hold
51
﹤0.01% 3833
2015
Q4
$26K Hold
51
﹤0.01% 3862
2015
Q3
$57K Buy
+51
New +$66.9K ﹤0.01% 3797

Other funds holding ONCS

BlackRock Institutional Trust's ONCS Position: Q4 2016 in Review

BlackRock Institutional Trust held its OncoSec Medical Incorporated (ONCS) position steady in Q4 2016 at 51 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3783.

BlackRock Institutional Trust first reported a position in ONCS in Q3 2015 and has held it in 6 quarters since. The position peaked at $57K in Q3 2015. 26 funds tracked by Wall St. Rank hold ONCS as of Q4 2016.

  • BlackRock Institutional Trust held 51 shares of OncoSec Medical Incorporated worth $14K as of Q4 2016.
  • BlackRock Institutional Trust left its OncoSec Medical Incorporated share count unchanged in Q4 2016.
  • OncoSec Medical Incorporated made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3783 holding.
  • BlackRock Institutional Trust first reported a position in OncoSec Medical Incorporated in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's OncoSec Medical Incorporated position peaked at $57K in Q3 2015.
  • 26 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.